Back

The pseudoproteinase iRhom2 critically promotes acute lung inflammation

Lux, C.; Kahveci-Tuerkoez, S.; Schun, K.; Babendreyer, A.; Martin, C.; Kasparek, P.; Sedlacek, R.; Duesterhoeft, S.; Ludwig, A.

2026-06-09 pharmacology and toxicology
10.64898/2026.06.05.730404 bioRxiv
Show abstract

ADAM17 sheds cell surface molecules such as TNF-, IL-6R and L-selectin. This activity requires either iRhom1 or iRhom2 as adapter molecules. Since iRhom2 is predominantly expressed in leukocytes and upregulated in tissue cells during inflammation, it represents a potential anti-inflammatory target. We therefore investigated the effects of iRhom2 deficiency in mice using in vivo, ex vivo, and in vitro models of acute inflammation. In an in vivo model of LPS-induced lung inflammation, iRhom2 knockout mice showed reduced neutrophil recruitment into the bronchoalveolar space. Notably, the few recruited neutrophils remained L-selectin positive, whereas most neutrophils in wildtype mice were L-selectin negative, confirming that L-selectin shedding depends on the iRhom2/ADAM17 axis. Furthermore, it suggests that impaired shedding is associated with decreased neutrophil recruitment. Additionally, ADAM17-dependent release of TNF- and IL-6R into the alveolar space was diminished in the absence of iRhom2, accompanied by reduced expression of inflammatory mediators. In isolated perfused lungs challenged with LPS, iRhom2 deficiency similarly reduced inflammatory mediator production, indicating a role for iRhom2 in resident lung tissue cells during the initiation of inflammation. To specifically assess immune cell responses, we further examined macrophages, the sole resident immune cells in the lung. In vitro, LPS-stimulated bone marrow derived macrophages lacking iRhom2 showed decreased shedding of TNF- and IL-6R and reduced induction of secondary inflammatory mediators. Thus, targeting iRhom2 effectively suppresses ADAM17-mediated inflammatory responses in the lung, while preserving basal ADAM17 activity through iRhom1, offering a more selective therapeutic strategy with fewer side effects. HighlightsO_LIThe ADAM17 adapter molecule iRhom2 is required for the acute lung inflammation of mice in vivo including cytokine response and neutrophil recruitment. C_LIO_LIIn resident lung tissue cells iRhom2 promotes the LPS induced inflammatory response at the alveolar interface. C_LIO_LIIn macrophages iRhom2 is required for an effective ADAM17 dependent inflammatory response to LPS. C_LIO_LIThus, iRhom2 targeting can serve to suppress inflammatory activities of ADAM17 in the lung. C_LI Graphical AbstractSchematic overview depicting the role of the iRhom2-ADAM17 axis in mediating neutrophil infiltration and cytokine release during induced pulmonary inflammation, serving as a model for acute lung injury (ALI). O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=165 SRC="FIGDIR/small/730404v1_ufig1.gif" ALT="Figure 1"> View larger version (74K): org.highwire.dtl.DTLVardef@e972d9org.highwire.dtl.DTLVardef@7326e0org.highwire.dtl.DTLVardef@1fd73bforg.highwire.dtl.DTLVardef@ba4031_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.1%
7.3%
2
European Respiratory Journal
59 papers in training set
Top 0.1%
6.8%
3
Cell Death Discovery
58 papers in training set
Top 0.1%
6.3%
4
eLife
5828 papers in training set
Top 25%
4.9%
5
JCI Insight
277 papers in training set
Top 2%
3.5%
6
EMBO Reports
263 papers in training set
Top 1%
3.3%
7
Redox Biology
70 papers in training set
Top 0.3%
3.2%
8
PLOS Pathogens
820 papers in training set
Top 5%
2.8%
9
Frontiers in Immunology
638 papers in training set
Top 4%
2.7%
10
Circulation Research
47 papers in training set
Top 0.6%
2.5%
11
Scientific Reports
3612 papers in training set
Top 42%
2.5%
12
Frontiers in Pharmacology
111 papers in training set
Top 1%
2.1%
13
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 0.7%
2.1%
14
iScience
1154 papers in training set
Top 15%
1.9%
50% of probability mass above
15
The FASEB Journal
194 papers in training set
Top 2%
1.7%
16
Nature Communications
5641 papers in training set
Top 45%
1.7%
17
Cell Death & Disease
126 papers in training set
Top 2%
1.7%
18
Cellular and Molecular Life Sciences
96 papers in training set
Top 0.8%
1.7%
19
International Journal of Molecular Sciences
494 papers in training set
Top 9%
1.5%
20
American Journal of Respiratory Cell and Molecular Biology
43 papers in training set
Top 0.5%
1.5%
21
British Journal of Pharmacology
40 papers in training set
Top 0.4%
1.5%
22
American Journal of Physiology-Lung Cellular and Molecular Physiology
43 papers in training set
Top 0.4%
1.5%
23
npj Regenerative Medicine
24 papers in training set
Top 0.5%
1.1%
24
BMC Medical Genomics
50 papers in training set
Top 0.8%
1.1%
25
The EMBO Journal
309 papers in training set
Top 5%
1.1%
26
Journal of Translational Medicine
57 papers in training set
Top 2%
1.0%
27
Stem Cells Translational Medicine
13 papers in training set
Top 0.3%
1.0%
28
PLOS ONE
5266 papers in training set
Top 57%
1.0%
29
Biomaterials
84 papers in training set
Top 1%
0.9%
30
Computational and Structural Biotechnology Journal
242 papers in training set
Top 7%
0.9%